In a malaria vaccine pilot program across 158 districts in Ghana, Kenya and Malawi, coverage, or the share of children eligible for each dose, reached about 80% for the first shot ...

Infectious bovine keratoconjunctivitis may be more complex than a single bacterial infection, opening new avenues for ...

Researchers cobbled together funding and time to show how quantum computing could aid in the development of drugs to help ...

The University of Maryland School of Medicine Center for Vaccine Development and Global Health (CVD), has announced the ...

Oxford Vaccine Group initiates the first Phase I trial for Bundibugyo ebolavirus vaccine with support from India's Serum ...

The small Ugandan city of Masaka is known mostly for its coffee, grown on rich volcanic soils that produce beans which have a ...

Vietnam and France have strengthened cooperation on next-generation vaccine technology as VNVC and Sanofi advance plans to ...

Scientists have taken a major step toward developing an effective HIV vaccine after a new experimental vaccine successfully ...

Oxford and Serum Institute have launched the first human trial of a vaccine targeting the deadly Bundibugyo strain of Ebola ...

Evaxion A/S (“Evaxion”), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology™ ...

The world’s first clinical trial of a vaccine targeting the Bundibugyo strain of Ebola has begun, marking a milestone in ...

For decades, the phrase “cancer vaccine” was the punchline of oncology conferences. We poured billions into stimulating T ...